Bio-Connect
WB analysis of various sample lysates using GTX53995 CD64 antibody. Dilution : 1:1000 Loading : 25microg per lane
WB analysis of various sample lysates using GTX53995 CD64 antibody. Dilution : 1:1000 Loading : 25microg per lane
WB analysis of various sample lysates using GTX53995 CD64 antibody. Dilution : 1:1000 Loading : 25microg per lane

CD64 antibody

GTX53995
GeneTex
ApplicationsWestern Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
TargetFCGR1A
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    CD64 antibody
  • Delivery Days Customer
    7
  • Application Supplier Note
    WB: 1:500 - 1:2000. IHC-P: 1:50 - 1:100. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Conjugate
    Unconjugated
  • Gene ID2209
  • Target name
    FCGR1A
  • Target description
    Fc gamma receptor Ia
  • Target synonyms
    CD64, CD64A, FCG1, FCGR1, FCRI, FcgammaRI, IGFR1, high affinity immunoglobulin gamma Fc receptor I, Fc fragment of IgG receptor Ia, Fc fragment of IgG, high affinity Ia, receptor (CD64), Fc fragment of IgG, high affinity Ia, receptor for (CD64), Fc-gamma RI, Fc-gamma receptor I A1, IgG Fc receptor I, fc-gamma RIA, fcgammaRIa
  • Host
    Rabbit
  • Isotype
    IgG
  • Protein IDP12314
  • Protein Name
    High affinity immunoglobulin gamma Fc receptor I
  • Scientific Description
    This gene encodes a protein that plays an important role in the immune response. This protein is a high-affinity Fc-gamma receptor. The gene is one of three related gene family members located on chromosome 1. [provided by RefSeq, Jul 2008]
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • Squalene-based nanoparticles for the targeting of atherosclerotic lesions. Brusini R et al., 2020 May 15, Int J Pharm
    Read more